Research
Hormonal
Newer antiobesity pharmacotherapies, particularly semaglutide and tirzepatide, have shown greater efficacy for weight reduction compared with older medications.
Newer medications may provide better options for weight management in patients with obesity.
StrongSupportsmedium confidence
Newer antiobesity pharmacotherapies, particularly semaglutide and tirzepatide, have shown greater efficacy for weight reduction compared with older medications.
Why this rating
The claim is based on a review of evidence regarding newer pharmacotherapies.
Source
Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction
Kevin C. Maki et al. · Expert Review of Endocrinology & Metabolism · 2023
reviewCited 14×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →